19.62
price down icon0.86%   -0.17
after-market Dopo l'orario di chiusura: 19.30 -0.32 -1.63%
loading

Viridian Therapeutics Inc Azioni (VRDN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
0.00%
0.072
0.072 0.072 0.072 0.098
Operating Expenses
21.78%
55.97
71.55 51.30 59.35 72.57
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
21.78%
55.97
71.55 51.30 59.35 72.57
Operating Income/Loss
21.80%
-55.90
-71.48 -51.22 -59.27 -72.47
Nonoperating Income/Loss
59.27%
7.355
4.618 3.564 4.212 4.322
Income/Loss From Continuing Operations Before Tax
0.00%
0.072
0.072 0.072 -55.06 -68.15
Income/Loss From Continuing Operations After Tax
27.40%
-48.54
-66.86 -47.66 -55.06 -68.15
Net Income/Loss
27.40%
-48.54
-66.86 -47.66 -55.06 -68.15
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,499%
61.10
1.6978 43.65 43.25 42.24
Diluted Average Shares
3,499%
61.10
1.6978 43.65 43.25 42.24
Basic Earnings Per Share
41.04%
-0.79
-1.34 -1.09 -1.27 -1.61
Diluted Earnings Per Share
41.04%
-0.79
-1.34 -1.09 -1.27 -1.61
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Capitalizzazione:     |  Volume (24 ore):